Daniele Mauro Selected Research

Vaccines

1/2022

Serological Response to BNT162b2 Anti-SARS-CoV-2 Vaccination in Patients with Inflammatory Rheumatic Diseases: Results From the RHEUVAX Cohort.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniele Mauro Research Topics

Disease

7	Rheumatoid Arthritis 03/2024 - 09/2012
5	Arthritis (Polyarthritis) 03/2024 - 12/2018
5	Inflammation (Inflammations) 03/2024 - 01/2018
4	Psoriatic Arthritis 04/2024 - 01/2022
2	Type 2 Diabetes Mellitus (MODY) 07/2023 - 01/2018
2	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 01/2018
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023 - 01/2021
2	Dysbiosis 01/2021 - 12/2019
2	Ankylosing Spondylitis 01/2021 - 11/2019
2	Axial Spondyloarthritis 01/2020 - 01/2019
2	Insulin Resistance 05/2015 - 09/2012
2	Anemia 01/2009 - 01/2009
1	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2024
1	Fever (Fevers) 11/2023
1	Hypertension (High Blood Pressure) 07/2023
1	Obesity 07/2023
1	Pharyngitis (Sore Throat) 01/2023
1	Serositis 01/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2022
1	Chronic Disease (Chronic Diseases) 04/2022
1	Fatigue 04/2022
1	Multifocal fibrosclerosis 01/2022
1	COVID-19 01/2022
1	HIV Infections (HIV Infection) 01/2022
1	Rheumatic Diseases (Rheumatism) 01/2022
1	Giant Cell Arteritis (Horton Disease) 12/2021
1	Nephritis 01/2021
1	Proteinuria 01/2021
1	Crohn Disease (Crohn's Disease) 01/2021
1	Lupus Nephritis 01/2021
1	Ileitis 01/2021
1	Multiple Sclerosis 11/2019
1	Neuroinflammatory Diseases 01/2018
1	Fatty Liver 10/2017
1	Non-alcoholic Fatty Liver Disease 10/2017

Drug/Important Bio-Agent (IBA)

2	guselkumabIBA 04/2024 - 01/2022
2	Methotrexate (Mexate)FDA LinkGeneric 03/2024 - 05/2015
2	Interleukin-17 (Interleukin 17)IBA 03/2024 - 01/2019
2	c-Mer Tyrosine KinaseIBA 03/2024 - 01/2021
2	Ferritins (Ferritin)IBA 11/2023 - 01/2023
2	secukinumabIBA 07/2023 - 11/2019
2	AutoantibodiesIBA 01/2023 - 12/2018
2	C-Reactive ProteinIBA 01/2021 - 10/2017
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2017
2	Complement C3 (C3 Complement)IBA 01/2018 - 10/2017
2	Abatacept (Orencia)FDA Link 05/2015 - 09/2012
1	Interleukin-23 Subunit p19IBA 03/2024
1	Antirheumatic Agents (DMARD)IBA 03/2024
1	InterleukinsIBA 03/2024
1	Interleukin-6 (Interleukin 6)IBA 03/2024
1	Phosphotransferases (Kinase)IBA 03/2024
1	Tyrosine (L-Tyrosine)FDA Link 03/2024
1	Monoclonal AntibodiesIBA 07/2023
1	ButyrophilinsIBA 01/2023
1	InterferonsIBA 01/2023
1	Immunomodulating AgentsIBA 04/2022
1	SteroidsIBA 04/2022
1	VaccinesIBA 01/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	BNT162 VaccineIBA 01/2022
1	Interleukin-18 (Interleukin 18)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021
1	curdlanIBA 01/2021
1	CreatinineIBA 01/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2021
1	InflammasomesIBA 01/2021
1	iberdomideIBA 01/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2020
1	LigandsIBA 01/2020
1	Interleukin-23 (Interleukin 23)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 12/2018
1	AntibodiesIBA 12/2018
1	AntigensIBA 12/2018
1	Interleukin-27 (Interleukin 27)IBA 12/2018
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018
1	RadiopharmaceuticalsIBA 01/2018
1	Complement System Proteins (Complement)IBA 10/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 09/2012
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2009
1	ThymolIBA 01/2009

Therapy/Procedure

3	Therapeutics 03/2024 - 12/2019
1	Precision Medicine 12/2021
1	Biological Therapy 12/2019
1	Aftercare (After-Treatment) 09/2012